Pharma-Bio Serv (PBSV) Other Working Capital Changes (2024 - 2025)
Pharma-Bio Serv's (PBSV) quarterly Other Working Capital Changes came in at -$37737.0 in Q1 2025, down 427.35% on a YoY basis from $11528.0 in Q1 2024, and down 427.35% quarter-over-quarter from $11528.0 in Q1 2024.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Other Working Capital Changes (2024 - 2025) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Other Working Capital Changes for 2 consecutive years, with $57624.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Other Working Capital Changes rose 143.19% year-over-year to $57624.0; the trailing twelve-month figure through Oct 2024 stood at $152429.0 (up 19.05% YoY), and the FY2025 full-year result was -$308312.0, down 1527.7% from the prior year.
- Other Working Capital Changes fell to -$37737.0 in Q1 2025 per PBSV's latest filing, from $11528.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $148841.0 in Q3 2023 and bottomed at -$133410.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2025 | -37,737.00 |
| Jan 31, 2025 | -37,737.00 |
| Jan 31, 2024 | 11,528.00 |
| Jan 31, 2024 | 11,528.00 |